Foresee plans FDA filing
Foresee to file for FDA approval of precocious puberty treatment, potentially expanding treatment options. This move may impact related pharmaceutical stocks.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.